摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[5-Amino-1-(chloromethyl)-1,2-dihydrobenzo[e]indol-3-yl]-3-(3-methoxyphenyl)prop-2-en-1-one

中文名称
——
中文别名
——
英文名称
1-[5-Amino-1-(chloromethyl)-1,2-dihydrobenzo[e]indol-3-yl]-3-(3-methoxyphenyl)prop-2-en-1-one
英文别名
——
1-[5-Amino-1-(chloromethyl)-1,2-dihydrobenzo[e]indol-3-yl]-3-(3-methoxyphenyl)prop-2-en-1-one化学式
CAS
——
化学式
C23H21ClN2O2
mdl
——
分子量
392.9
InChiKey
VRBJCJNVLXEKKP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    55.6
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl-(amine- derived)] compounds and analogues thereof, and to products obtained therefrom
    申请人:Denny Alexander William
    公开号:US20050148651A1
    公开(公告)日:2005-07-07
    The invention provides processes of preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3H-[ring fused indol-5-yl(amine-derived)] compounds of formula (I) and its analogues, or a physiologically functional derivative thereof, (I), wherein A and B together may represent a fused optionally substituted benezene, naphthalene, pyridine, furan or a pyrrole ring, where the optional substituents are represented by Y; X is halogen or OSO 2 R, and W is selected from NO 2 , NHOH, N(R 3 ) 2 NHR 3 , NHCO 2 R 3 , N(phthaloyl) or NH 2 , or W is further selected from the group (a), wherein J is selected from OH or R, and P is a group which is a substrate suitable for a nitroreductase or carboxypeptidase enzyme. The invention is also directed to the use of compounds of formula (I) prepared by the processes of the invention as cytotoxins for cancer therapy and as prodrugs for gene-directed enzyme-prodrug therapy (GDEPT) and antibody-directed enzyme-prodrug therapy (ADEPT).
    本发明提供了制备式(I)及其类似物或其生理功能衍生物的3-取代-1-(甲基)-1,2-二氢-3H-[环融合吲哚-5-基(基衍生)]化合物的过程,其中A和B在一起可以表示为融合的可选取代苯、吡啶呋喃吡咯环,其中可选的取代基由Y表示;X是卤素或OSO2R,W从NO2、NHOH、N(R3)2NHR3、NHCO2R3、N(phthaloyl)或NH2中选择,或者W进一步从(a)组中选择,其中J从OH或R中选择,P是适用于硝基还原酶或羧肽酶酶的底物基团。本发明还涉及使用通过本发明的方法制备的式(I)化合物作为癌症治疗的细胞毒素以及基因导向酶前药治疗(GDEPT)和抗体导向酶前药治疗(ADEPT)的前药。
  • CYCLOPROPYLINDOLE COMPOUNDS AND THEIR USE AS PRODRUGS
    申请人:AUCKLAND UNISERVICES LIMITED
    公开号:EP0938474B1
    公开(公告)日:2005-11-23
  • US6130237A
    申请人:——
    公开号:US6130237A
    公开(公告)日:2000-10-10
  • US7235578B2
    申请人:——
    公开号:US7235578B2
    公开(公告)日:2007-06-26
查看更多